Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Early features of autism spectrum disorder: a cross-sectional study.

Parmeggiani A, Corinaldesi A, Posar A.

Ital J Pediatr. 2019 Nov 14;45(1):144. doi: 10.1186/s13052-019-0733-8.

2.

Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.

Abruzzo PM, Matté A, Bolotta A, Federti E, Ghezzo A, Guarnieri T, Marini M, Posar A, Siciliano A, De Franceschi L, Visconti P.

J Transl Med. 2019 Oct 2;17(1):332. doi: 10.1186/s12967-019-2076-z.

3.

Mild Phenotype Associated with SLC6A1 Gene Mutation: A Case Report with Literature Review.

Posar A, Visconti P.

J Pediatr Neurosci. 2019 Apr-Jun;14(2):100-102. doi: 10.4103/jpn.JPN_2_19.

4.

Autism spectrum disorder today: not only genetics.

Posar A, Visconti P.

Turk Pediatri Ars. 2019 Jul 11;54(2):137-138. doi: 10.14744/TurkPediatriArs.2019.98216. eCollection 2019. No abstract available.

5.

The thousand faces of autism spectrum disorder.

Posar A, Visconti P.

Turk Pediatri Ars. 2018 Dec 1;53(4):273-274. doi: 10.5152/TurkPediatriArs.2018.18066. eCollection 2018 Dec. No abstract available.

6.

Infantile autism and Mitteleuropa.

Posar A, Visconti P.

Turk Pediatri Ars. 2018 Dec 1;53(4):271-272. doi: 10.5152/TurkPediatriArs.2018.18065. eCollection 2018 Dec. No abstract available.

7.

Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid Asymmetry.

Bolotta A, Battistelli M, Falcieri E, Ghezzo A, Manara MC, Manfredini S, Marini M, Posar A, Visconti P, Abruzzo PM.

Oxid Med Cell Longev. 2018 Nov 11;2018:6430601. doi: 10.1155/2018/6430601. eCollection 2018.

8.

Na+ , K+ -ATPase activity in children with autism spectrum disorder: Searching for the reason(s) of its decrease in blood cells.

Bolotta A, Visconti P, Fedrizzi G, Ghezzo A, Marini M, Manunta P, Messaggio E, Posar A, Vignini A, Abruzzo PM.

Autism Res. 2018 Oct;11(10):1388-1403. doi: 10.1002/aur.2002. Epub 2018 Aug 18.

9.

Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.

Anwar A, Abruzzo PM, Pasha S, Rajpoot K, Bolotta A, Ghezzo A, Marini M, Posar A, Visconti P, Thornalley PJ, Rabbani N.

Mol Autism. 2018 Feb 19;9:3. doi: 10.1186/s13229-017-0183-3. eCollection 2018.

10.

Neurodevelopmental Disorders between Past and Future.

Posar A, Visconti P.

J Pediatr Neurosci. 2017 Jul-Sep;12(3):301-302. doi: 10.4103/jpn.JPN_95_17. No abstract available.

11.

Tribute to Grunya Efimovna Sukhareva, the Woman who First Described Infantile Autism.

Posar A, Visconti P.

J Pediatr Neurosci. 2017 Jul-Sep;12(3):300-301. doi: 10.4103/jpn.JPN_46_17. No abstract available.

12.

Sensory abnormalities in children with autism spectrum disorder.

Posar A, Visconti P.

J Pediatr (Rio J). 2018 Jul - Aug;94(4):342-350. doi: 10.1016/j.jped.2017.08.008. Epub 2017 Nov 4. Review.

13.

High predictive values of RBC membrane-based diagnostics by biophotonics in an integrated approach for Autism Spectrum Disorders.

Giacometti G, Ferreri C, Sansone A, Chatgilialoglu C, Marzetti C, Spyratou E, Georgakilas AG, Marini M, Abruzzo PM, Bolotta A, Ghezzo A, Minguzzi R, Posar A, Visconti P.

Sci Rep. 2017 Aug 29;7(1):9854. doi: 10.1038/s41598-017-10361-7.

14.

Autism Spectrum Disorders: The Troubles with the Diagnostic and Statistical Manual of Mental Disorders 5th Edition.

Posar A, Visconti P.

J Pediatr Neurosci. 2017 Jan-Mar;12(1):114-115. doi: 10.4103/jpn.JPN_147_16. No abstract available.

15.

Authors' reply: "Autism in 2016: additional discovery".

Posar A, Visconti P.

J Pediatr (Rio J). 2017 May - Jun;93(3):309-310. doi: 10.1016/j.jped.2016.12.002. Epub 2016 Dec 28. No abstract available.

16.

Neuropsychiatric phenotype in a child with pseudohypoparathyroidism.

Visconti P, Posar A, Scaduto MC, Russo A, Tamburrino F, Mazzanti L.

J Pediatr Neurosci. 2016 Jul-Sep;11(3):267-270.

17.

Omega-3 supplementation in autism spectrum disorders: A still open question?

Posar A, Visconti P.

J Pediatr Neurosci. 2016 Jul-Sep;11(3):225-227.

18.

Autism in 2016: the need for answers.

Posar A, Visconti P.

J Pediatr (Rio J). 2017 Mar - Apr;93(2):111-119. doi: 10.1016/j.jped.2016.09.002. Epub 2016 Nov 9. Review.

19.

Long-term follow-up of cognitive functions in patients with continuous spike-waves during sleep (CSWS).

Maltoni L, Posar A, Parmeggiani A.

Epilepsy Behav. 2016 Jul;60:211-217. doi: 10.1016/j.yebeh.2016.04.006. Epub 2016 May 27.

PMID:
27240307
20.

Complementary and Alternative Medicine in Autism: The Question of Omega-3.

Posar A, Visconti P.

Pediatr Ann. 2016 Mar;45(3):e103-7. doi: 10.3928/00904481-20160129-01. Review.

PMID:
27031309

Supplemental Content

Loading ...
Support Center